Page 74 - Read Online

Page 12 of 14 Jayachandran et al. Hepatoma Res 2020;6:8 I http://dx.doi.org/10.20517/2394-5079.2019.35

45. Hsing AW, McLaughlin JK, Olsen JH, Mellemkjar L, Wacholder S, et al. Cancer risk following primary hemochromatosis: a
population-based cohort study in Denmark. Int J Cancer 1995;60:160-2.
46. Strohmeyer G, Niederau C, Stremmel W. Survival and causes of death in hemochromatosis. Observations in 163 patients. Ann N Y
Acad Sci 1988;526:245-57.
47. Yang Q, McDonnell SM, Khoury MJ, Cono J, Parrish RG. Hemochromatosis-associated mortality in the United States from 1979 to
1992: an analysis of Multiple-Cause Mortality Data. Ann Intern Med 1998;129:946-53.
48. Cauza E, Peck-Radosavljevic M, Ulrich-Pur H, Datz C, Gschwantler M, et al. Mutations of the HFE gene in patients with
hepatocellular carcinoma. Am J Gastroenterol 2003;98:442-7.
49. Ezzikouri S, El Feydi AE, El Kihal L, Afifi R, Benazzouz M, et al. Prevalence of common HFE and SERPINA1 mutations in patients
with hepatocellular carcinoma in a Moroccan population. Arch Med Res 2008;39:236-41.
50. Fargion S, Stazi MA, Fracanzani AL, Mattioli M, Sampietro M, et al. Mutations in the HFE gene and their interaction with exogenous
risk factors in hepatocellular carcinoma. Blood Cells Mol Dis 2001;27:505-11.
51. Hellerbrand C, Pöppl A, Hartmann A, Schölmerich J, Lock G. HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for
an increased prevalence. Clin Gastroenterol Hepatol 2003;1:279-84.
52. Lauret E, Rodríguez M, González S, Linares A, López-Vázquez A, et al. HFE gene mutations in alcoholic and virus-related cirrhotic
patients with hepatocellular carcinoma. Am J Gastroenterol 2002;97:1016-21.
53. Nahon P, Sutton A, Rufat P, Ziol M, Thabut G, et al. Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in
patients with cirrhosis. Gastroenterology 2008;134:102-10.
54. Pirisi M, Toniutto P, Uzzau A, Fabris C, Avellini C, et al. Carriage of HFE mutations and outcome of surgical resection for
hepatocellular carcinoma in cirrhotic patients. Cancer 2000;89:297-302.
55. Ropero P, Briceño O, López-Alonso G, Agúndez JA, González Fernández FA, et al. The H63D mutation in the HFE gene is related to
the risk of hepatocellular carcinoma. Rev Esp Enferm Dig 2007;99:376-81. (in Spanish)
56. Shi WJ, Chen H, Zhou B, Cheng J. Association of mutations of HFE gene and hepatocellular carcinoma following chronic hepatitis B.
Zhonghua Gan Zang Bing Za Zhi 2005;13:682-4. (in Chinese)
57. Willis G, Wimperis JZ, Lonsdale R, Fellows IW, Watson MA, et al. Incidence of liver disease in people with HFE mutations. Gut
2000;46:401-4.
58. Willis G, Wimperis JZ, Lonsdale R, Jennings BA. Haemochromatosis gene mutation in hepatocellular cancer. Lancet 1997;350:565-6.
59. Sánchez-Luna SA, Brown KE. Clinical burden of liver disease from hemochromatosis at an academic medical center. Hepatol
Commun 2017;1:453-9.
60. Ellervik C, Birgens H, Tybjaerg-Hansen A, Nordestgaard BG. Hemochromatosis genotypes and risk of 31 disease endpoints: meta-
analyses including 66,000 cases and 226,000 controls. Hepatology 2007;46:1071-80.
61. Ye Q, Qian BX, Yin WL, Wang FM, Han T. Association between the HFE C282Y, H63D polymorphisms and the risks of non-
alcoholic fatty liver disease, liver cirrhosis and hepatocellular carcinoma: an updated systematic review and meta-analysis of 5,758
cases and 14,741 controls. PLoS One 2016;11:e0163423.
62. Asberg A, Hveem K, Thorstensen K, Ellekjter E, Kannelønning K, et al. Screening for hemochromatosis: high prevalence and low
morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 2001;36:1108-15.
63. Gharib AF, Karam RA, Pasha HF, Radwan MI, Elsawy WH. Polymorphisms of hemochromatosis, and alpha-1 antitrypsin genes in
Egyptian HCV patients with and without hepatocellular carcinoma. Gene 2011;489:98-102.
64. Harrison SA, Bacon BR. Relation of hemochromatosis with hepatocellular carcinoma: epidemiology, natural history, pathophysiology,
screening, treatment, and prevention. Med Clin North Am 2005;89:391-409.
65. Tarao K, Nozaki A, Ikeda T, Sato A, Komatsu H, et al. Real impact of liver cirrhosis on the development of hepatocellular carcinoma
in various liver diseases-meta-analytic assessment. Cancer Med 2019;8:1054-65.
66. Villanueva A, Newell P, Hoshida Y. Inherited hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 2010;24:725-34.
67. Bradbear RA, Bain C, Siskind V, Schofield FD, Webb S, et al. Cohort study of internal malignancy in genetic hemochromatosis and
other chronic nonalcoholic liver diseases. J Natl Cancer Inst 1985;75:81-4.
68. Blanc JF, De Ledinghen V, Bernard PH, de Verneuil H, Winnock M, et al. Increased incidence of HFE C282Y mutations in patients
with iron overload and hepatocellular carcinoma developed in non-cirrhotic liver. J Hepatol 2000;32:805-11.
69. Hiatt T, Trotter JF, Kam I. Hepatocellular carcinoma in a noncirrhotic patient with hereditary hemochromatosis. Am J Med Sci
2007;334:228-30.
70. Asare GA, Mossanda KS, Kew MC, Paterson AC, Kahler-Venter CP, et al. Hepatocellular carcinoma caused by iron overload: a
possible mechanism of direct hepatocarcinogenicity. Toxicology 2006;219:41-52.
71. Willis G, Bardsley V, Fellows IW, Lonsdale R, Wimperis JZ, et al. Hepatocellular carcinoma and the penetrance of HFE C282Y
mutations: a cross sectional study. BMC Gastroenterol 2005;5:17.
72. Fracanzani AL, Fargion S, Stazi MA, Valenti L, Amoroso P, et al. Association between heterozygosity for HFE gene mutations and
hepatitis viruses in hepatocellular carcinoma. Blood Cells Mol Dis 2005;35:27-32.
73. Nowak A, Giger RS, Krayenbuehl PA. Higher age at diagnosis of hemochromatosis is the strongest predictor of the occurrence of
hepatocellular carcinoma in the Swiss hemochromatosis cohort: a prospective longitudinal observational study. Medicine (Baltimore)
2018;97:e12886.
74. Boige V, Castéra L, de Roux N, Ganne-Carrié N, Ducot B, et al. Lack of association between HFE gene mutations and hepatocellular
carcinoma in patients with cirrhosis. Gut 2003;52:1178-81.
75. Jin F, Qu LS, Shen XZ. Association between C282Y and H63D mutations of the HFE gene with hepatocellular carcinoma in European
populations: a meta-analysis. J Exp Clin Cancer Res 2010;29:18.
76. Campo S, Restuccia T, Villari D, Raffa G, Cucinotta D, et al. Analysis of haemochromatosis gene mutations in a population from the